Condition: Stroke, Acute · Comorbidities and Coexisting Conditions · Critical Care · Sponsor: University of Giessen
The aim of the planned study project is to assess the current situation regarding the treatment of patients with stroke. Specifically, various treatment strategies are to be associated and correlated with clinical endpoints, mortality or functional outcome in order to generate arguments for or against individual aspects of therapy. The focus will be on unresolved treatment approaches in acute therapy (e.g. periprocedural management, such as blood pressure, blood glucose, temperature, or airway management, during recanalizing therapies) as well as in secondary prevention on the stroke unit or intensive care unit, such as starting point, mode, and dosage of antithrombotic therapies.
This description comes directly from the study's public registry record.
Tobias Braun, M.D. · +49641-985 · tobias.braun@neuro.med.uni-giessen.de
Martin Juenemann, M.D., M.Sc. · +49641-985 · martin.juenemann@neuro.med.uni-giessen.de
Always discuss trial participation with your own doctor first.
| Universitätsklinikum Gießen | Giessen, Hesse, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05295862